China SXT Pharmaceuticals, Inc. (SXTC) › EPS (Diluted)China SXT Pharmaceuticals, Inc. (SXTC) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2017: $0.062018: $0.062019: $0.072020: $33.282021: $-3.822022: $-137.922023: $-177.842024: $-28.582025: $-2.32$-2.322017EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-2.32+91.9%2024$-28.58+83.9%2023$-177.84-28.9%2022$-137.92-3511.4%2021$-3.82-111.5%2020$33.28+44276.0%2019$0.07+27.1%2018$0.06+0.0%2017$0.06—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share